Top Markets
#1 PulseChain PulseChain +43.68%
#2 Bitway Bitway +9.47%
#3 Fake World Assets Fake World Assets +8.69%
#4 eCash eCash +7.79%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.28%
#6 Meteora Meteora +6.01%
#7 EthereumPoW EthereumPoW +5.75%
#8 Velvet Velvet +5.32%
#9 Bitcoin SV Bitcoin SV +5.29%
#10 Creditcoin Creditcoin +5.17%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Classifica tra le azioni #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Prezzo delle azioni
$0.39748785
Ultima sincronizzazione: 2026-08-19
Capitalizzazione di mercato
$27.51M
Variazione (1 giorno)
-4.21%
Variazione (1 anno)
-48.76%
Paese
TW
Scambia LAUNXP Biomedical Co., Ltd (6876)

Categoria

Healthcare
Rapporto P/S per LAUNXP Biomedical Co., Ltd (6876)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di LAUNXP Biomedical Co., Ltd, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per LAUNXP Biomedical Co., Ltd da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH